ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Amgen's quick Aimovig launch boosts blockbuster hopes for Lilly, Teva and Alder: analyst
August 21, 2018Amgen's migraine prevention drug Aimovig, just approved in May, is riding a rising wave of early demand—and that's a good thing, not just for Amgen and its partner Novartis, but for other forthcoming drugs in the CGRP class, an analyst said Monday. -
Analyst chastises Mylan—not known for its transparency—for under-the-radar dealmaking
August 17, 2018Mylan unveiled plenty of news in its second-quarter earnings release last week, including that its revenues were down year over year and that it was lowering guidance. But there was also some key info it didn’t include.
Pharma Sources Insight January 2025
